Hone first-AE offer: negotiate, then likely take — 0.5% at $1B is a strong headline, not $5M in hand

Asked (summary)

Evaluate the tech behind Hone's "Closing the gap" post — is it truly legit?

Asked (follow-up)

“let's assume they give me an offer for first AE of .5% of the company, which is $5m given their new $1bn valuation. Should i take it? Or still not ideal given other AE opportunities at AI companies?”

This follow-up weighs the offer against 36 benchmark rows: 12 current equity benchmarks for founding-AE and first-sales-hire roles (broad public range 0.5%–1.5%, some leadership roles to 4%), 12 enterprise AE on-target-earnings listings clustering $325K–$450K, and 12 equity-diligence sources on dilution, 409A strike costs, liquidation preferences, vesting and tax. Verdict: strong enough to take seriously — but verify the terms first, and never treat 0.5% of a $1B preferred valuation as a $5M grant.

All equity outcomes below are illustrative and pre-tax, not forecasts. This is general research, not individualized legal, tax or investment advice — use an attorney and tax adviser on the actual documents.

The decision gate: where this offer sits today

Three gates. The offer as described lands in the middle one — negotiate the written terms, then likely take.

Gate 1

Take

Signed grant equals 0.50% fully diluted, post-financing, post-pool
Standard 4-year vesting is the only major condition
Cash plan roughly market: realistic OTE near $300K+
Repeatable paying customers; credible founder-led motion
Exercise cost and strike are manageable

Current answer

Negotiate, then likely take

0.5% at a genuine $1B mark is unusually strong for an IC first AE — benchmarks put 0.5%–1.5% at far earlier, far cheaper companies
But "$5M" is a headline ownership mark: options vest, dilute, sit behind preferred, and cost strike and tax
Keep the full 0.50%; seek market cash, 6-month ramp guarantee, quota/territory protections, a 0.10%–0.25% milestone grant, longer exercise window, double-trigger acceleration
Run the 9-question checklist below before signing

Gate 3

Walk

"0.5%" is verbal, pre-round, or excludes the expanded pool
Board approval vague; performance-vested against unproven quota
Realistic OTE materially below ~$300K with little validated pipeline
Impressive demos but no repeatable sales process; heavy custom implementations
Company won't clarify cap-table denominator, strike cost or sales evidence

The $5M headline versus what 0.5% could actually be worth

Illustrative, pre-tax gross common-equity value of the grant after an assumed 35% cumulative dilution by 2029 (0.50% → 0.325% fully vested), before strike cost, taxes and liquidation-preference effects. Scenarios use the prior report's $6B 2029 headline case plus $2B and $1B outcomes. Hover a bar for detail.

0.5% against early sales-hire equity benchmarks

Published equity ranges for founding AE, first sales hire and early sales-leadership roles (12 rows). These companies are generally far earlier and much less valuable than a $1B company — so 0.5% at $1B is unusually strong for an individual contributor, though defensible if the hire must build the GTM function. Hover a bar for the source.

The cash opportunity cost: enterprise AE OTE benchmarks

On-target earnings from 12 current enterprise/strategic AE benchmarks and named listings. Against an illustrative $250K startup OTE, a $350K–$400K alternative creates $100K–$150K of annual target-compensation risk before attainment — not every rep attains OTE. The equity must justify that gap.

Nine questions to get in writing before signing

Each question maps to a documented failure mode in the equity-diligence sources linked.

What the charts cannot say alone

Enterprise AE OTEs in the 12 benchmark rows run $325K to $450K (average about $366K); Anthropic's named Strategic Growth AE listing shows $380K OTE — the realistic cash bar a startup plan must be judged against. boards.greenhouse.io

Every one of the 12 equity benchmarks for first sales hires sits at pre-seed to Series A companies; the common 0.5%–1.5% first-AE band applies to firms worth a small fraction of $1B, which makes 0.5% at a genuine $1B mark unusually strong for an IC. startuproles.co

Early-stage 409A common-stock value is typically only 25–35% of the latest preferred price, and a company with $50M of liquidation preferences must exit well above that before employee options are worth anything meaningful. opencapstack.com

The standard 90-day post-termination exercise window can wipe out vested options; some companies grant 5–10 years, and a refusal to extend it in writing is itself information about how the company views your risk. capwolf.com

All benchmark rows

Equity benchmarks (percent of company) and OTE benchmarks (US$), with sources.

Type	Role / company	Stage or location	Equity %	OTE / base	Source

Method: 36 rows across three curated result sets collected in 2026 — 12 early sales-hire equity benchmarks (percent of fully diluted company, low–high published range), 12 enterprise AE OTE benchmarks and named listings (on-target earnings in US$, base where published), and 12 startup-equity diligence sources (dilution, 409A, preferences, vesting, exercise windows, AMT). Scenario values are illustrative pre-tax gross figures assuming 35% cumulative dilution and full or 75% vesting; strike cost, taxes and liquidation preferences are not modeled. Diligence mitigations are condensed for space. Not individualized legal, tax or investment advice.

This report was generated automatically by Keenable SELECT at a user's request, from publicly available web sources linked herein. Keenable does not review, verify, or endorse its contents and makes no representation as to accuracy, completeness, or timeliness; AI-based extraction may contain errors. Nothing in this report is investment, legal, financial, or other professional advice. All trademarks and referenced content remain the property of their respective owners; no affiliation or endorsement is implied. To report an error, rights concern, or request removal: legal@keenable.ai.